(Q36452704)

14 August 2017

1 reference

title

Current status and perspective of angiogenesis and antivascular therapeutic strategy: non-small cell lung cancer (English)

1 reference

14 August 2017

6

Saburo Sone

1 reference

14 August 2017

Seiji Yano

1

1 reference

14 August 2017

Yuka Matsumori

2

1 reference

14 August 2017

Kenji Ikuta

3

1 reference

14 August 2017

Hirokazu Ogino

4

1 reference

14 August 2017

Tamir Doljinsuren

5

1 reference

14 August 2017

language of work or name

1 reference

1 April 2006

1 reference

International Journal of Clinical Oncology

14 August 2017

1 reference

14 August 2017

11

1 reference

14 August 2017

2

1 reference

14 August 2017

73-81

1 reference

https://scigraph.springernature.com/pub.10.1007/s10147-006-0568-3

14 August 2017

0 references

cites work

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1007%2FS10147-006-0568-3

Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-006-0568-3

Tumor angiogenesis and accessibility: role of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-006-0568-3

Transplacental carcinogenesis by stilbestrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-006-0568-3

Bone metastasis model with multiorgan dissemination of human small-cell lung cancer (SBC-5) cells in natural killer cell-depleted SCID mice

21 January 2018

1 reference

12 December 2020

Glomeruloid microvascular proliferation is superior to intratumoral microvessel density as a prognostic marker in non-small cell lung cancer

1 reference

12 December 2020

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

1 reference

12 December 2020

Model of malignant pleural effusion of human lung adenocarcinoma in SCID mice.

1 reference

12 December 2020

Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors

1 reference

12 December 2020

Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice.

1 reference

12 December 2020

Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer

1 reference

12 December 2020

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

1 reference

12 December 2020

Expression of angiopoietins and its clinical significance in non-small cell lung cancer

1 reference

12 December 2020

Clinical trials of antiangiogenic drugs: opportunities, problems, and assessment of initial results

1 reference

12 December 2020

Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase.

1 reference

12 December 2020

Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma

1 reference

12 December 2020

Molecular mechanisms of angiogenesis in non-small cell lung cancer, and therapeutics targeting related molecules

1 reference

12 December 2020

Phosphorylation, But Not Overexpression, of Epidermal Growth Factor Receptor Is Associated With Poor Prognosis of Non-Small Cell Lung Cancer Patients

1 reference

12 December 2020

Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer

1 reference

12 December 2020

Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody

1 reference

12 December 2020

Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lun

1 reference

12 December 2020

Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis.

1 reference

12 December 2020

The seed and soil hypothesis: vascularisation and brain metastases

1 reference

12 December 2020

Antiangiogenesis drugs target specific cancers, mechanisms

1 reference

12 December 2020

Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839).

1 reference

12 December 2020

Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.

1 reference

12 December 2020

Vascular endothelial growth factor in malignant pleural effusion associated with lung cancer

1 reference

12 December 2020

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

1 reference

12 December 2020

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

12 December 2020

Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.

1 reference

12 December 2020

ZD6474, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, inhibits growth of experimental lung metastasis and production of malignant pleural effusions in a non-small cell lung cancer model

1 reference

12 December 2020

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

12 December 2020

The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis

1 reference

12 December 2020

ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase.

1 reference

12 December 2020

Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis

1 reference

12 December 2020

The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer

1 reference

12 December 2020

Sensitization of tumor-associated endothelial cell apoptosis by the novel vascular-targeting agent ZD6126 in combination with cisplatin

1 reference

12 December 2020

The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis

1 reference

12 December 2020

Lung Cancer Highlights from ASCO 2005.

1 reference

12 December 2020

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

1 reference

12 December 2020

Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis.

1 reference

12 December 2020

Why the epidermal growth factor receptor? The rationale for cancer therapy

1 reference

12 December 2020

Angiogenesis and lung cancer: prognostic and therapeutic implications

1 reference

12 December 2020

Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.

1 reference

12 December 2020

Antitumor vascular strategy for controlling experimental metastatic spread of human small-cell lung cancer cells with ZD6474 in natural killer cell-depleted severe combined immunodeficient mice.

1 reference

12 December 2020

Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin

1 reference

12 December 2020

From angiogenesis to lymphangiogenesis

1 reference

12 December 2020

Novel metastasis model of human lung cancer in SCID mice depleted of NK cells

1 reference

12 December 2020

Angiogenesis as a Prognostic Indicator of Survival in Non-Small-Cell Lung Carcinoma: a Prospective Study

1 reference

12 December 2020

Gefitinib--a novel targeted approach to treating cancer

1 reference

12 December 2020

Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor

1 reference

12 December 2020

Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice.

1 reference

12 December 2020

Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer

1 reference

12 December 2020

VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma

1 reference

12 December 2020

ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration.

1 reference

12 December 2020

Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer

1 reference

12 December 2020

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

1 reference

12 December 2020

10.1007/S10147-006-0568-3

Identifiers

DOI

1 reference

14 August 2017

1 reference